Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Agarwal Vineet | Nov 11, 2024 | Sell | 800 | $70 | $56,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 4,961 | $80.5027 | $400,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 2,023 | $71.509 | $140,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 1,815 | $79.7911 | $140,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 457 | $78.5857 | $36,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 317 | $81.48 | $26,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 260 | $77.5548 | $20,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 164 | $73.7116 | $12,000 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 115 | $74.5609 | $8,600 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 56 | $76 | $4,300 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 25 | $82.89 | $2,100 |
| Agarwal Vineet | Oct 17, 2024 | Sell | 23 | $77 | $1,800 |
| Atlas Venture Opportunity Fund II, L.P. | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| Chang Carmen | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| New Enterprise Associates 17, L.P. | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| BASKETT FOREST | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| Walker Paul Edward | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| Florence Anthony A. Jr. | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| Mathers Edward T | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| Yang Rick | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| Makhzoumi Mohamad | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| SANDELL SCOTT D | Apr 22, 2024 | Buy | 17,857 | $56 | $1,000,000 |
| Lucchino David L. | Nov 22, 2023 | Sell | 614 | $37.9844 | $23,000 |
| Lucchino David L. | Nov 22, 2023 | Sell | 230 | $36.7391 | $8,400 |
| Lucchino David L. | Nov 22, 2023 | Sell | 202 | $38.8195 | $7,800 |
| Lucchino David L. | Nov 22, 2023 | Sell | 110 | $35.9873 | $4,000 |
| Lucchino David L. | Nov 10, 2023 | Sell | 373 | $39.5889 | $15,000 |
| Lucchino David L. | Nov 10, 2023 | Sell | 225 | $43.172 | $9,700 |
| Lucchino David L. | Nov 10, 2023 | Sell | 191 | $44.0134 | $8,400 |
| Lucchino David L. | Nov 10, 2023 | Sell | 67 | $45.5281 | $3,100 |
| Lucchino David L. | Nov 10, 2023 | Sell | 41 | $41.9427 | $1,700 |
| Lucchino David L. | Nov 10, 2023 | Sell | 37 | $37.9242 | $1,400 |
| Lucchino David L. | Nov 10, 2023 | Sell | 34 | $46.225 | $1,600 |
What's the latest insider transaction for Korro Bio?
The most recent insider transaction for Korro Bio was conducted by Agarwal Vineet, who sold 800 shares on November 11, 2024 at a price of $70.00 per share.
Which insider bought the most KRRO stock over the last two years?
SANDELL SCOTT D has bought the most KRRO stock in the last 2 years, with a total value of $1,000,000.
Which insider has sold the most KRRO stock over the last two years?
Agarwal Vineet has sold the most KRRO stock in the last 2 years, with a total value of $860,000.
What is the total value of insider transactions for Korro Bio (KRRO) in the last 2 years?
According to our estimates, the total value of insider transactions for Korro Bio in the last 2 years is positive, amounting to $9.1M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Korro Bio's market confidence?
Over the last 2 years, insider transactions for Korro Bio have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
